Doubling the field reimbursement team targets prior authorization friction, a hurdle that can stall prescriptions even after demand is established.
Ardelyx, Inc. (ARDX) News
Latest headlines that mention ARDX, newest first · each headline opens the original publisher
- Last price
- $2.94
- Day change
- -1.67%
- Next earnings
- —
ARDX headlines
last 30 daysPatient awareness push and IBSRELA sales growth both gained momentum this quarter.
ARDX news alerts
Get an alert by email or push when a new headline mentions ARDX.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.